You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/63648
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSaad, W. A.-
dc.contributor.authorCamargo, L. A A-
dc.date.accessioned2014-05-26T21:57:47Z-
dc.date.accessioned2016-10-25T18:11:47Z-
dc.date.available2014-05-26T21:57:47Z-
dc.date.available2016-10-25T18:11:47Z-
dc.date.issued1984-01-01-
dc.identifierhttp://dx.doi.org/10.1159/000137967-
dc.identifier.citationPharmacology, v. 28, n. 4, p. 228-234, 1984.-
dc.identifier.issn0031-7012-
dc.identifier.urihttp://hdl.handle.net/11449/63648-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/63648-
dc.description.abstractThe effects of sodium and potassium excretion after intrahypothalamic administration of two α-adrenoceptor agonists and the effect of α-adrenoceptor antagonists were studied in groups of rats. Prazosin was equally effective at blocking the natriuretic and kaliuretic responses to the α1-adrenoceptor agonist phenylephrine and the mixed α1/α2-adrenoceptor agonist noradrenaline, while yohimbine which acts preferentially on α2-adrenoceptors was effective in potentiating these responses. These results suggest the presence of two types of α-adrenoceptors for the modulation of ventromedial hypothalamic pathways that interfere with the regulation of the two cations: stimulation of α1-adrenoceptors facilitates, while stimulation of α2-adrenoceptors inhibits the excretion of the ions.en
dc.format.extent228-234-
dc.language.isoeng-
dc.sourceScopus-
dc.subjectalpha 1 adrenergic receptor-
dc.subjectalpha 2 adrenergic receptor-
dc.subjectalpha adrenergic receptor stimulating agent-
dc.subjectnoradrenalin-
dc.subjectphenylephrine-
dc.subjectprazosin-
dc.subjectyohimbine-
dc.subjectanimal experiment-
dc.subjectcentral nervous system-
dc.subjectkidney-
dc.subjectnonhuman-
dc.subjectpotassium urine level-
dc.subjectrat-
dc.subjectsodium urine level-
dc.subjectzona incerta-
dc.subjectAdrenergic alpha-Agonists-
dc.subjectAdrenergic alpha-Antagonists-
dc.subjectAnimal-
dc.subjectDogs-
dc.subjectDose-Response Relationship, Drug-
dc.subjectHypothalamus, Middle-
dc.subjectNorepinephrine-
dc.subjectPhenylephrine-
dc.subjectPotassium-
dc.subjectPrazosin-
dc.subjectRabbits-
dc.subjectRats-
dc.subjectSodium-
dc.subjectSupport, Non-U.S. Gov't-
dc.subjectYohimbine-
dc.titleEffects of the application of α1- and α2-adrenoceptor agonists and antagonists into the ventromedial hypothalamus on the sodium and potassium renal excretionen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.identifier.doi10.1159/000137967-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofPharmacology-
dc.identifier.scopus2-s2.0-0021362154-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.